Plegridy approved for relapsing remitting MS in England

NICE has published its final decision recommending that Plegridy can be prescribed by the NHS for relapsing remitting MS.

In May 2018, NICE carried out a review of several of the MS drugs and decided that Avonex, Extavia, Rebif, Copaxone and Brabio should continue to be available on the NHS in England. At the time, NICE was unable to make a recommendation on Plegridy and has now completed a separate appraisal.

The MS Trust contributed throughout the process.

We are pleased that NICE has approved Plegridy for people with relapsing remitting MS. We were able to make a strong case to NICE thanks to those of you who told us about your experiences of taking this treatment and the importance of having a greater choice of disease modifying drugs.

- David Martin, Chief Executive Officer, MS Trust

Plegridy (peginterferon beta 1a) is a disease modifying drug for relapsing remitting MS which you inject once a fortnight. Plegridy is already approved for use in Scotland and Wales.

Find out more about Plegridy.

Find out more

NICE decision
Plegridy
Disease modifying drugs
MS Decisions - find out about disease modifying drugs for relapsing MS

Ponesimod (Ponvory) for relapsing remitting multiple sclerosis rejected by NICE

13 Oct 2021 - 00:00

The MS Trust is very disappointed that NICE does not recommend ponesimod (Ponvory) as an NHS treatment in England and Wales.

Multiple sclerosis and disease modifying drugs, what are my options?

28 Sep 2021 - 00:00

We interview Dr Sharmilee Gnanapavan, a Consultant Neurologist at Bart's Health to get some answers on what's new in the world of disease modifying drugs and multiple sclerosis.

New report highlights barriers to accessing Sativex across the UK

18 Aug 2021 - 00:00

Fewer than 13% of people in England eligible for Sativex can access it, according to a new report published today. People living in Wales, Scotland and Northern Ireland also face difficulties.

Move it for MS Nick's story

7 Oct 2021 - 00:00

Nick, was diagnosed with relapsing remitting multiple sclerosis at the start of the first lockdown. In this story we talk to him about how he coped with his diagnosis and how running helps him with his MS.

David's diary - Inclusion and diversity, where are we now?

6 Oct 2021 - 00:00

Just over a year ago we published a diary entry about Inclusivity and Diversity at the MS Trust. In this piece we take a look at what's changed since then and what we still need to do.

Flu season 2021

4 Oct 2021 - 00:00

This year is likely to involve a bigger flu vaccination programme in the UK, including for people with multiple sclerosis (MS), due to the circulation of Covid-19 at the same time. Here we discuss who's eligible for a flu jab on the NHS and how to get one.